ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company developing, manufacturing, and commercializing innovative and high-quality therapeutics as we transform into a leading Rare Disease company.
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology
2026-04-07
ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Financial Guidance
2026-02-27
$80.83
+3.64 ( 4.71% )
Pricing delayed by 20 minutes
Last updated
2026-04-07 14:25:00